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Goals	  
•  Develop	  a	  combinaEon	  of	  small	  molecule	  
compounds	  capable	  of	  reprogramming	  mouse	  
somaEc	  cells	  into	  pluripotent	  stem	  cells	  in	  the	  
absence	  of	  exogenous	  “master	  genes”	  
VC6T	  
Table	  S1	  (B)	  
Name	   Abbrevia+on	   Func+on	   Structure	  
Valproic	  acid	  sodium	  
salt	  
VPA,	  V	   Histone	  deacetylase	  
inhibitor	  
CHIR99021	   CHIR,	  C	   GSK3-­‐β	  inhibitor	  
616452	   6	   TGF-­‐β	  inhibitor	  
Tranylcypromine	   Tranyl,	  T	   H3K4	  demethylaEon	  
inhibitor	  
•  Part	  1:	  Find	  Oct4	  subs+tute	  
•  Part	  2:	  Test	  small	  molecule	  cocktail	  
•  Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
•  Part	  4:	  Resolve	  incomplete	  reprogramming	  
•  Part	  5:	  OpEmize	  cocktail	  
•  Part	  6:	  Screen	  for	  reprogramming	  booster	  
•  Part	  7:	  AddiEonal	  cells	  of	  origin	  
•  Part	  8:	  Characterize	  CiPSC	  lines	  
•  Part	  9:	  Determine	  essenEal	  small	  molecules	  
•  Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Part	  1:	  Find	  Oct4	  SubsEtute	  
Mice:	  
•  OG	  -­‐	  Oct4/EGFP	  transgenic	  C57BL/6J	  mice	  
carrying	  EGFP	  (enhanced	  green	  ﬂuorescence	  
protein)	  under	  control	  of	  an	  Oct4	  18-­‐kb	  
genomic	  fragment	  containing	  the	  minimal	  
promoter	  and	  proximal	  and	  distal	  enhancers;	  
can	  come	  close	  to	  mimicking	  the	  endogenous	  
embryonic	  expression	  paqern	  of	  Oct-­‐4	  in	  
transgenic	  mice	  
Part	  1:	  Find	  Oct4	  SubsEtute	  
Methods:	  
•  LenEviral	  infecEon:	  Sox2,	  Klf4	  and	  c-­‐Myc	  (SKM)	  
•  Small	  molecule	  screen	  
–  20k	  OG	  MEFs/well;	  12	  well	  plate	  
–  Infect	  with	  lenEvirus	  encoding	  SKM	  
–  Replace	  with	  LIF-­‐free	  ESC	  culture	  medium	  
–  Add	  individual	  chemicals	  from	  small-­‐molecule	  libraries	  to	  each	  
well	  
–  Change	  medium	  and	  chemicals	  every	  4	  days	  
–  14-­‐20	  days	  or	  unEl	  GFP+	  colonies	  
–  Primary	  hits	  conﬁrmed	  and	  opEmized	  
Two	  SupporEng	  Factors	  Greatly	  Improve	  the	  Eﬃciency	  of	  Human	  iPSC	  GeneraEon,	  Cell	  Stem	  Cell,	  Volume	  3,	  Issue	  5,	  
6	  November	  2008,	  Pages	  475-­‐479,	  ISSN	  1934-­‐5909,	  hqp://dx.doi.org/10.1016/j.stem.2008.10.002.	  
Part	  1:	  Find	  Oct4	  SubsEtute	  
Small	  molecule	  libraries	  
Table	  S1	  (A)	  
Part	  1:	  Find	  Oct4	  SubsEtute	  
Fig.	  1	  
SKM/SK:	  Primary	  hits	  
Part	  1:	  Find	  Oct4	  SubsEtute	  
Table	  S1	  (B)	  
Name	   Abbrevia+on	   Func+on	   Structure	  




2-­‐Me-­‐5HT	   5-­‐HT3	  agonist	  	  
D4476	   CK1	  inhibitor	  
SKM/SK:	  Primary	  hits	  
Part	  1:	  Find	  Oct4	  SubsEtute	  
Fig.	  S1	  
CharacterizaEon	  of	  iPSC	  colonies	  induced	  from	  SKM	  or	  
SK-­‐infected	  MEFs	  with	  FSK	  treatment	  
Part	  1:	  Find	  Oct4	  SubsEtute	  
Fig.	  S2	  
CharacterizaEon	  of	  iPSC	  colonies	  induced	  from	  SKM	  or	  
SK-­‐infected	  MEFs	  with	  2-­‐Me-­‐5HT	  or	  D4476	  treatment	  
•  Part	  1:	  Find	  Oct4	  subsEtute	  
•  Part	  2:	  Test	  small	  molecule	  cocktail	  
•  Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
•  Part	  4:	  Resolve	  incomplete	  reprogramming	  
•  Part	  5:	  OpEmize	  cocktail	  
•  Part	  6:	  Screen	  for	  reprogramming	  booster	  
•  Part	  7:	  AddiEonal	  cells	  of	  origin	  
•  Part	  8:	  Characterize	  CiPSC	  lines	  
•  Part	  9:	  Determine	  essenEal	  small	  molecules	  
•  Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Part	  2:	  Test	  small	  molecule	  cocktail	  
Name	   Abbrevia+on	   Func+on	   Structure	  
Valproic	  acid	  sodium	  
salt	  
VPA,	  V	   Histone	  deacetylase	  
inhibitor	  
CHIR99021	   CHIR,	  C	   GSK3-­‐β	  inhibitor	  
616452	   6	   TGF-­‐β	  inhibitor	  
Tranylcypromine	   Tranyl,	  T	   H3K4	  demethylaEon	  
inhibitor	  
Forskolin	   FSK,	  F	   AcEvates	  adenylate	  
cyclase	  
VC6TF	  
Table	  S1	  (B)	  




•  Plate	  cells:	  50k/well;	  6	  well	  plate	  
•  Replace	  medium	  with	  chemical	  
reprogramming	  medium	  containing	  small	  
molecule	  cocktail	  
•  Change	  medium	  every	  4	  days	  
Part	  2:	  Test	  small	  molecule	  cocktail	  
VC6TF:	  CharacterizaEon	  of	  GFP+	  clusters;	  day	  24	  
Fig.	  S3	  
•  Part	  1:	  Find	  Oct4	  subsEtute	  
•  Part	  2:	  Test	  small	  molecule	  cocktail	  
•  Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
•  Part	  4:	  Resolve	  incomplete	  reprogramming	  
•  Part	  5:	  OpEmize	  cocktail	  
•  Part	  6:	  Screen	  for	  reprogramming	  booster	  
•  Part	  7:	  AddiEonal	  cells	  of	  origin	  
•  Part	  8:	  Characterize	  CiPSC	  lines	  
•  Part	  9:	  Determine	  essenEal	  small	  molecules	  
•  Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
Mice:	  	  
•  Infected	  OG	  MEFs	  	  




•  Infect	  OG	  MEFs	  with	  Fu-­‐tet-­‐hOct4	  and	  FUdeltaGW-­‐reTA	  
lenEviruses	  
•  Culture	  medium	  containing	  VC6T	  and	  DOX	  (DOX	  ﬁrst	  4-­‐8	  days)	  
•  Individual	  chemicals	  from	  small-­‐molecule	  library	  in	  each	  well	  
•  Change	  medium	  and	  chemicals	  every	  4	  days	  
•  ConEnue	  16-­‐24	  days	  or	  unEl	  GFP+	  colonies	  appear	  
•  Conﬁrm	  and	  opEmize	  primary	  hits	  
Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
Fig.	  S4	  
Name	   Abbrevia+on	   Func+on	   Structure	  
3-­‐deazaneplanocin	   DZNep,	  Z	   S-­‐Adenosylhomocysteine	  
Hydrolase	  inhibitor	  and	  
histone	  methyltransferase	  
EZH2	  inhibitor	  
Table	  S1	  (B)	  
VC6T	  +	  DOX:	  Primary	  hits	  
	  
Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
Table	  S1	  (B)	  
Name	   Abbrevia
+on	  
Func+on	   Structure	  
Valproic	  acid	  sodium	  
salt	  
VPA,	  V	   Histone	  deacetylase	  inhibitor	  
CHIR99021	   CHIR,	  C	   GSK3-­‐β	  inhibitor	  
616452	   6	   TGF-­‐β	  inhibitor	  
Tranylcypromine	   Tranyl,	  T	   H3K4	  demethylaEon	  inhibitor	  
Forskolin	   FSK,	  F	   AcEvates	  adenylate	  cyclase	  
3-­‐deazaneplanocin	   DZNep,	  Z	   S-­‐Adenosylhomocysteine	  
Hydrolase	  inhibitor	  and	  histone	  
methyltransferase	  EZH2	  inhibitor	  
VC6TFZ	  
Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
VC6TFZ:	  GFP	  posiEve	  cells	  induced	  
Fig.	  1	  
Fig.	  S5	  
•  Part	  1:	  Find	  Oct4	  subsEtute	  
•  Part	  2:	  Test	  small	  molecule	  cocktail	  
•  Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
•  Part	  4:	  Resolve	  incomplete	  reprogramming	  
•  Part	  5:	  OpEmize	  cocktail	  
•  Part	  6:	  Screen	  for	  reprogramming	  booster	  
•  Part	  7:	  AddiEonal	  cells	  of	  origin	  
•  Part	  8:	  Characterize	  CiPSC	  lines	  
•  Part	  9:	  Determine	  essenEal	  small	  molecules	  
•  Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Part	  4:	  Resolve	  incomplete	  reprogramming	  
Fig.	  1	  
VC6TFZ:	  Emeline	  of	  CiPSC	  generaEon	  
Part	  4:	  Resolve	  incomplete	  reprogramming	  
Fig.	  S6	  
VC6TFZ:	  RNA-­‐seq	  analysis	  of	  GFP	  posiEve	  colonies	  
(without	  2i	  medium/incomplete)	  and	  CiPSCs	  
Heat	  map:	  
• Value	  in	  the	  color	  key	  indicates	  log2	  
changes	  
• Generated	  using	  R	  
Part	  4:	  Resolve	  incomplete	  reprogramming	  
2i	  medium:	  
•  Small	  molecule	  inhibiEon	  of	  MAP	  kinase	  (MEK)	  
and	  glycogen	  synthase	  kinase	  3	  (GSK3)	  
•  MEK	  inhibiEon	  is	  the	  main	  reprogramming	  cue	  in	  
2i	  and	  also	  exerts	  selecEon	  against	  pre-­‐iPS	  cells	  
–  Phospho-­‐Erk	  (p-­‐Erk)	  signal	  exEnguished	  
–  UpregulaEon	  of	  Nanog	  expression	  	  	  
•  GSK	  inhibiEon	  generates	  intracellular	  β-­‐catenin,	  
which	  interacts	  with	  Tcf3	  and	  abolishes	  its	  
repressor	  eﬀect	  on	  mulEple	  genes	  in	  the	  
pluripotent	  network	  
•  GSK	  inhibiEon	  also	  supports	  embryonic	  stem	  cell	  
propagaEon	  through	  sEmulatory	  eﬀects	  on	  
metabolic	  and	  biosyntheEc	  processes	  
•  2i	  treatment	  does	  not	  select	  for	  expansion	  of	  an	  
already	  resident	  pluripotent	  subpopulaEon,	  but	  
acEvely	  induces	  conversion	  to	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
pluripotency	  in	  pre-­‐iPS	  cell	  
Hamazaki	  et	  al,	  2006	  
Wray	  et	  al,	  2011	  
•  Part	  1:	  Find	  Oct4	  subsEtute	  
•  Part	  2:	  Test	  small	  molecule	  cocktail	  
•  Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
•  Part	  4:	  Resolve	  incomplete	  reprogramming	  
•  Part	  5:	  Op+mize	  cocktail	  
•  Part	  6:	  Screen	  for	  reprogramming	  booster	  
•  Part	  7:	  AddiEonal	  cells	  of	  origin	  
•  Part	  8:	  Characterize	  CiPSC	  lines	  
•  Part	  9:	  Determine	  essenEal	  small	  molecules	  
•  Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Part	  5:	  OpEmize	  cocktail	  
Fig.	  S7	  
VC6TFZ:	  concentraEons	  and	  treatment	  duraEons	  of	  
individual	  chemicals	  
•  Part	  1:	  Find	  Oct4	  subsEtute	  
•  Part	  2:	  Test	  small	  molecule	  cocktail	  
•  Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
•  Part	  4:	  Resolve	  incomplete	  reprogramming	  
•  Part	  5:	  OpEmize	  cocktail	  
•  Part	  6:	  Screen	  for	  reprogramming	  booster	  
•  Part	  7:	  AddiEonal	  cells	  of	  origin	  
•  Part	  8:	  Characterize	  CiPSC	  lines	  
•  Part	  9:	  Determine	  essenEal	  small	  molecules	  
•  Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Part	  6:	  Screen	  for	  reprogramming	  booster	  
Fig.	  S8	  
VC6TFZ	  +	  TTNPB:	  eﬀect	  of	  TTNPB	  and	  characterizaEon	  
of	  generated	  CiPSCs	  
Part	  6:	  Screen	  for	  reprogramming	  booster	  
VC6TFZ	  +	  TTNPB:	  eﬀect	  of	  TTNPB	  and	  characterizaEon	  
of	  generated	  CiPSCs	  
Name	   Abbrevia+on	   Func+on	   Structure	  
TTNPB	   N	   SelecEve	  and	  highly	  potent	  reEnoic	  acid	  
analog	  with	  aﬃnity	  for	  reEnoic	  acid	  
receptors	  (RAR)	  α,	  β,	  and	  γ,	  which	  are	  
nuclear	  transcripEon	  factors.	  Produces	  
ligand-­‐acEvated	  transcripEon	  of	  genes	  
that	  possess	  reEnoic	  acid	  responsive	  
elements.	  
Table	  S1	  (B)	  
•  Part	  1:	  Find	  Oct4	  subsEtute	  
•  Part	  2:	  Test	  small	  molecule	  cocktail	  
•  Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
•  Part	  4:	  Resolve	  incomplete	  reprogramming	  
•  Part	  5:	  OpEmize	  cocktail	  
•  Part	  6:	  Screen	  for	  reprogramming	  booster	  
•  Part	  7:	  Addi+onal	  cells	  of	  origin	  
•  Part	  8:	  Characterize	  CiPSC	  lines	  
•  Part	  9:	  Determine	  essenEal	  small	  molecules	  
•  Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Part	  7:	  AddiEonal	  cells	  of	  origin	  
Methods:	  
•  Plate	  cells:	  50k/well;	  6	  well	  plate	  
•  Replace	  medium	  with	  chemical	  reprogramming	  medium	  containing	  
small	  molecule	  cocktail	  
•  Change	  medium	  every	  4	  days	  
•  DZNep	  added	  day	  16	  or	  day	  20	  
•  Small	  molecule	  cocktail	  (including	  DZNep)	  removed	  day	  20;	  replace	  
with	  2i	  medium	  
Fig.	  1	  
Part	  7:	  AddiEonal	  cells	  of	  origin	  
Fig.	  S9	  
VC6TFZ:	  morphology	  of	  CiPSC	  colonies	  generated	  from	  MNFs,	  
MAFs,	  ADSCs	  and	  WT	  MEFs;	  genomic	  PCR	  analyzing	  pOct4-­‐GFP	  





•  Part	  1:	  Find	  Oct4	  subsEtute	  
•  Part	  2:	  Test	  small	  molecule	  cocktail	  
•  Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
•  Part	  4:	  Resolve	  incomplete	  reprogramming	  
•  Part	  5:	  OpEmize	  cocktail	  
•  Part	  6:	  Screen	  for	  reprogramming	  booster	  
•  Part	  7:	  AddiEonal	  cells	  of	  origin	  
•  Part	  8:	  Characterize	  CiPSC	  lines	  
•  Part	  9:	  Determine	  essenEal	  small	  molecules	  
•  Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ:	  CiPSCs	  free	  of	  transgene	  contaminaEon	  
Fig.	  S10	  




Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ	  
MNF	   ADSC	  
MAF	   WT	  MEF	  
Fig.	  S12	  
Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ	  
Fig.	  S13	  
Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ:	  Histone	  H3	  modiﬁcaEons	  at	  Oct4,	  Sox2	  and	  
Nanog	  promoter	  regions	  
Fig.	  S14	  
Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ:	  geneEc	  integrity	  of	  CiPSCs	  
Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ:	  pluripotency	  of	  CiPSCs	  
Fig.	  3	  
Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ:	  pluripotency	  of	  CiPSCs	  
Fig.	  S15	  
Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ:	  in	  vivo	  developmental	  potenEal	  of	  CiPSCs	  
Fig.	  S16	  
•  Part	  1:	  Find	  Oct4	  subsEtute	  
•  Part	  2:	  Test	  small	  molecule	  cocktail	  
•  Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
•  Part	  4:	  Resolve	  incomplete	  reprogramming	  
•  Part	  5:	  OpEmize	  cocktail	  
•  Part	  6:	  Screen	  for	  reprogramming	  booster	  
•  Part	  7:	  AddiEonal	  cells	  of	  origin	  
•  Part	  8:	  Characterize	  CiPSC	  lines	  
•  Part	  9:	  Determine	  essen+al	  small	  molecules	  
•  Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Part	  9:	  Determine	  essenEal	  small	  
molecules	  
Fig.	  4	  
Part	  9:	  Determine	  essenEal	  small	  
molecules	  
Fig.	  S20	  
CharacterizaEon	  of	  CiPSCs	  induced	  by	  C6FZ	  
•  Part	  1:	  Find	  Oct4	  subsEtute	  
•  Part	  2:	  Test	  small	  molecule	  cocktail	  
•  Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  
•  Part	  4:	  Resolve	  incomplete	  reprogramming	  
•  Part	  5:	  OpEmize	  cocktail	  
•  Part	  6:	  Screen	  for	  reprogramming	  booster	  
•  Part	  7:	  AddiEonal	  cells	  of	  origin	  
•  Part	  8:	  Characterize	  CiPSC	  lines	  
•  Part	  9:	  Determine	  essenEal	  small	  molecules	  
•  Part	  10:	  Inves+gate	  role	  of	  small	  molecules	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S17	  
Biological	  acEvity	  of	  FSK	  during	  chemical	  
reprogramming	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  4	  
FuncEon	  of	  DZNep	  in	  chemical	  reprogramming	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S18	  
FuncEon	  of	  DZNep	  in	  chemical	  reprogramming	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S19	  
FuncEon	  of	  DZNep	  in	  chemical	  reprogramming	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S21	  
VC6TFZ:	  Gene	  expression	  during	  chemical	  
reprogramming	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
VC6TFZ:	  Gene	  expression	  during	  chemical	  
reprogramming	  
Fig.	  4	   Fig.	  S29	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S22	  &	  S23	  




Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S24	  
VC6TFZ:	  eﬀect	  of	  speciﬁc	  chemicals	  on	  gene	  expression	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S25	  
Overexpression	  of	  Sall4	  and	  Sox2:	  Oct-­‐4	  promoter-­‐
driven	  luciferase	  reporter	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S26	  
Fig.	  4	  
VTZ:	  overexpression	  of	  Sall4	  and	  Sox2	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S27	  
VC6TFZ:	  Eﬀects	  of	  knockdown	  on	  gene	  expression	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S28	  
VC6TFZ:	  Eﬀects	  of	  knockdown	  on	  expression	  of	  Oct4	  
and	  iPSC	  formaEon	  





•  Human	  somaEc	  cells	  
•  Improve	  eﬃciency	  
•  DiﬀerenEaEon	  of	  CiPSCs	  
•  Direct	  reprogramming	  
AddiEonal	  informaEon	  
Part	  1:	  Find	  Oct4	  SubsEtute	  
Fig.	  S1	  
CharacterizaEon	  of	  iPSC	  colonies	  induced	  from	  SKM	  or	  
SK-­‐infected	  MEFs	  with	  FSK	  treatment	  
Methods:	  
• Immunoﬂuorescence	  
-­‐Primary	  anEbodies:	  SSEA-­‐1,	  OCT4,	  NANOG,	  UTF1	  




• 10-­‐15	  CiPSCs	  into	  embryo	  cavity	  of	  F2	  or	  CD-­‐1	  
female	  mice	  at	  3.5	  days	  post	  coitum	  
• Transferred	  into	  2.5	  day	  pseudopregnant	  
females	  
-­‐Eight	  cell	  embryo	  injecEon:	  
• XYClone	  laser	  system	  
• Collected	  from	  female	  mice	  at	  2.5	  days;	  7-­‐10	  
CiPSCs	  injected	  into	  each	  embryo	  
• Transferred	  into	  .5	  day	  pseudopregnant	  
females	  
-­‐Chimeric	  mice	  idenEﬁed	  by	  coat	  color	  




-­‐Convert	  to	  cDNA	  
-­‐Carry	  out	  PCR	  
-­‐Analysis	  of	  data	  using	  delta-­‐delta	  Ct	  method	  
• Scaqer	  plot	  –	  DNA	  microarray	  
-­‐Total	  mRNA	  was	  labeled	  with	  Cy5,	  hybridized	  to	  a	  
mouse	  Oligo	  Microarray	  
-­‐Red	  line	  =	  boundary	  for	  two-­‐fold	  change	  
-­‐R	  =	  Pearson’s	  coeﬃcient	  
Cell	  culture	  
•  Cells	  used	  in	  reprogramming	  were	  passage	  1-­‐5	  
•  Cells	  cultured	  in	  DMEM/High	  glucose	  containing	  10%	  fetal	  
bovine	  serum	  
•  ESCs,	  iPSCs	  and	  CiPSCs	  maintained	  on	  feeder	  layers	  of	  
mitomycin	  C-­‐treated	  (halts	  division)	  MEFs	  in	  ESC	  culture	  
medium	  (KnockOut	  DMEM	  containing	  10%	  knockout	  serum	  
replacement,	  10%	  FBS,	  2mM	  GlutaMAX-­‐I,	  1%	  nonessenEal	  
amino	  acids,	  0.1	  mM	  2-­‐mercaptoethanol,	  1%	  penicillin-­‐
streoEnycin	  and	  1,000	  U/ml	  leukemia	  inhibitory	  factor)	  
•  For	  CiPSC	  inducEon,	  LIF-­‐free	  ESC	  culture	  medium	  
supplemented	  with	  20-­‐100ng/ml	  bFGF	  
Part	  2:	  Test	  small	  molecule	  cocktail	  
VC6TF:	  CharacterizaEon	  of	  GFP+	  clusters;	  day	  24	  
Fig.	  S3	  
Methods:	  
• Bisulﬁte	  genomic	  sequencing	  
-­‐Genomic	  DNA	  modiﬁed	  by	  bisulﬁte	  treatment	  and	  puriﬁed	  
-­‐Ampliﬁed	  fragments	  cloned	  into	  pEASY-­‐blunt	  vector	  
-­‐Ten	  randomly	  picked	  clones	  from	  each	  sample	  were	  sequenced	  
• RNA-­‐seq:	  	  
-­‐RNA	  sequencing	  libraries	  constructed	  
-­‐Fragmented	  and	  randomly	  primed	  200bp	  paired-­‐end	  libraries	  were	  
sequenced	  using	  Illumina	  HiSeq	  2000	  
Part	  3:	  Screen	  for	  late	  reprogramming	  molecule	  




Flow	  cytometry	  analysis:	  
• Cultured	  cells	  trypsinized	  into	  single	  cells	  and	  
resuspended	  in	  PBS	  containing	  3%	  FBS	  
• Using	  endogenous	  Oct4-­‐GFP,	  FACS	  analyses	  
preformed	  with	  FACSCalibur	  instrument	  










Table	  S1	  (B)	  
Fig.	  S13	  
Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ:	  Histone	  H3	  modiﬁcaEons	  at	  Oct4,	  Sox2	  and	  
Nanog	  promoter	  regions	  
Methods:	  
ChromaEn	  immunoprecipitaEon	  (ChIP):	  
• EZ-­‐Magna	  ChIP	  A/G	  kit	  
• AnE-­‐H3K27me3,	  AnE-­‐H3K9me2,	  AnE-­‐H3K4me3,	  
AnE-­‐H3K9ac	  anEbodies	  used	  
• Following	  immunoprecipitaEon,	  DNA	  analyzed	  by	  
real-­‐Eme	  PCR	  
Fig.	  S14	  
Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ:	  geneEc	  integrity	  of	  CiPSCs	  
CompariEve	  genomic	  hybridizaEon	  
analysis:	  
• Genomic	  DNA	  extracted	  and	  




•  105	  iPS	  cells	  were	  injected	  into	  the	  kidney	  capsule	  of	  one	  severe	  combined	  
immunodeﬁcient	  beige	  mouse	  
•  	  Teratomas	  were	  recovered	  4	  weeks	  a~er	  gra~ing	  
•  Control	  mice	  were	  injected	  with	  1	  million	  MEFs	  and	  failed	  to	  form	  teratoma	  
•  Embedded	  in	  paraﬃn	  and	  processed	  with	  hematoxylin	  and	  eosin	  staining	  
Part	  8:	  Characterize	  CiPSC	  lines	  
VC6TFZ:	  pluripotency	  of	  CiPSCs	  
Fig.	  3	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
Fig.	  S25	  
Overexpression	  of	  Sall4	  and	  Sox2:	  Oct-­‐4	  promoter-­‐
driven	  luciferase	  reporter	  
Methods:	  
• MEFs	  plated	  40,000	  cells/well;	  
24	  well	  plate	  
• Transiently	  transfected	  with	  
Oct4	  promoter	  reporters	  using	  
Lipofetamine	  LTX	  and	  Plus	  
Reagent	  
• pRL-­‐TK	  plasmids	  cotransfected	  
in	  each	  well	  as	  internal	  
references	  
• Total	  DNA	  concentraEons	  for	  
all	  transfecEons	  were	  equalized	  
by	  adding	  empty	  pLL3.7-­‐ΔU6	  
vector	  
• At	  48	  hours,	  cells	  washed	  and	  
lysed	  
• Luciferase	  acEvity	  measured	  
with	  Dual-­‐luciferase	  Reporter	  
Assay	  system	  and	  normalized	  to	  
Renilla	  luciferase	  acEvity	  
• Empty	  expression	  vector	  
plasmids	  used	  as	  negaEve	  
control	  
shRNA	  silencing	  
Part	  10:	  InvesEgate	  role	  of	  small	  molecules	  
VC6TFZ:	  Eﬀects	  of	  knockdown	  on	  gene	  expression	  
Fig.	  S27	  
